Risk for COVID-19 breakthrough infection increased for cancer patients
A recent study published in JAMA Oncology has shown that [...]
COVID-19 vaccines, boosters and immunity webinar
The National Core Studies Immunity (NCSi) Programme and UK Coronavirus Immunology Consortium (UK-CIC) are [...]
First bivalent COVID-19 booster vaccine approved by UK medicines regulator
An updated version of the COVID-19 vaccine that targets two [...]
COVID-19 and cancer: Immunotherapy and immunosuppressive cancer therapies
This review summarises the outcomes of people with COVID-19 taking [...]
Breakthrough COVID-19 infections in vaccinated cancer patients
This study used real world data from the National COVID [...]
Moderna’s COVID-19 vaccine may be more effective for cancer patients
Growing evidence from America suggests that patients with cancer have [...]
COVID-19: Delay of third jab for extremely vulnerable
Studies have shown that people who are immunosuppressed - around [...]
ESMO 2021: Cancer and COVID-19: Outcomes and risk factors
This year there was some very important data presented at [...]
ESMO 2021: COVID-19 vaccine in cancer patients is comparable to the general population
The latest findings from five studies presented at the ESMO [...]
Immunotherapy and COVID-19 in cancer patients
A recent review published in the Journal for ImmunoTherapy of [...]
